AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a $16.5 million outlay. Eli Lilly and Boehringer Ingelheim’s ...

Senior Telugu Desam Party (TDP) leader and former MLA Sugavasi Palakondarayudu died of illness while undergoing treatment at a hospital in Bengaluru on Tuesday. He was a four-time MLA and was also ...

In this article, we will take a look at where AbbVie Inc. (NYSE:ABBV) stands against other top stock recommendations by ChatGPT. After a two-year surge of 53%, the stock market has been taken for ...

These two policies could have major impacts on AbbVie, Lilly, and Johnson & Johnson. Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market ...

AbbVie Inc. ABBV, a biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company's stock traded at ...

Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products in the U.S., they still import some drugs and ingredients used in the products. Steep pharmaceutical tariffs ...

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to ...

AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the Trump administration. On a conference call to discuss AbbVie's first ...

AbbVie Inc. took a little shot at the Trump administration’s trade policy, as the drugmaker said Friday that rather than tariffs, tax reform is the key to boosting U.S. manufacturing. The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...